CCND1 and ovarian carcinoma: Flow cytometry results showed that compared with the ANXA114‐26 group, the apoptotic cells in the ANXA114‐26+OE‐Cyclin D1 group decreased, indicating that overexpression of Cyclin D1 could reverse the inhibitory effect of ANXA114‐26 on ovarian cancer cells (Figure 5I).